BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023
Home » Authors » Cynthia Robbins-Roth

Cynthia Robbins-Roth

Articles

ARTICLES

Force Care Foundation Brings Military Opportunities to Bio-Entrepreneurs

Oct. 10, 2012
By Cynthia Robbins-Roth
No Comments
Last autumn, I was searching for a way to get rid of the nerve-zapping pain that hit every time the barometer made a steep jump. My face full of post-plane crash titanium and regenerated bone acted like a weather station. I couldn’t find doctors with experience in my kind of injury. “Folks with injuries like yours are usually dead . . .” My husband turned to the military world, with the recent flood of soldiers with faces and other body parts that need rebuilding. He found a team at Lackland Air Force Base in Texas reporting on repairing maxillofacial trauma...
Read More

Spring Has Sprung! Venture Funding up for Biotech in Q1

April 4, 2012
By Cynthia Robbins-Roth
No Comments
The birds are chirping, the garden is blooming and biotech is raking in the bucks – at least in the context of the past few years.
Read More

Biotech Rings in 2012 With a Toast to 2011 VC Tallies

Jan. 4, 2012
By Cynthia Robbins-Roth
No Comments
It was another heart attack-inducing year for biotech fans, with the market gyrations approaching the speed of light.
Read More

When Frank Talks, Everyone Listens But Will They Act?

Nov. 1, 2011
By Cynthia Robbins-Roth
No Comments
No Abstract
Read More

VC Investments in Biotech Dip 12%, But Deal Size Doubles

Oct. 5, 2011
By Cynthia Robbins-Roth
No Comments
The steady drip, drip, drip of excess stomach acid experienced by biotech venture capitalists, institutional investors and employees is sadly in sync with the steady drip, drip, drip of capital away from the sector.
Read More

Biotech Sector Perks Up, But is it Enough to be Giddy?

July 6, 2011
By Cynthia Robbins-Roth
No Comments
I was dreading doing the calculations for 2011's second quarter venture rounds.
Read More

1Q11 Venture Rounds, IPOs: Spring Comes in Like a Lamb

April 5, 2011
By Cynthia Robbins-Roth
No Comments
It's officially spring, and we made it past April Fool's Day still intact. News from the Middle East and the Pacific Rim is scary, but the stock market has had its best quarter in a while. So how did it work out for private biotech firms last quarter, and what might lie ahead? (BioWorld Perspectives)
Read More

2010 Figures Show How to Get Past Series A Rounds

Jan. 26, 2011
By Cynthia Robbins-Roth
No Comments
The good news about fundraising in 2010: Initial public offerings (IPOs) warmed up.
Read More

Limping Toward the Finish Line in Third-Quarter 2010

Oct. 5, 2010
By Cynthia Robbins-Roth
No Comments

Is Venture Riding the Summer Roller Coaster?

July 20, 2010
By Cynthia Robbins-Roth
No Comments
View All Articles by Cynthia Robbins-Roth

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 22, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 22, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • New NLRP3 inflammasome inhibitors named in PTC Therapeutics patent

    BioWorld Science
    PTC Therapeutics Inc. has patented new NLRP3 inflammasome inhibitors reported to be useful...
  • Illustration of Alzheimer’s in the brain.

    Study identifies cause of death for Alzheimer’s neurons

    BioWorld
    By creating a new mouse model of Alzheimer’s disease that better recapitulated how the disease plays out in humans, investigators at KU Leuven have gained new...
BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing